FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/06/089585 [Registered on: 25/06/2025] Trial Registered Prospectively
Last Modified On: 25/06/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Single Arm Study 
Public Title of Study   Reduction Of Abnormal Involuntary Movemrnts of antipsychotics using Homoeopathic Medicines 
Scientific Title of Study   A PROSPECTIVE OPEN LABEL SINGLE ARM STUDY ON THE EFFECTIVENESS OF HOMOEOPATHIC MEDICINES IN REDUCING THE ABNORMAL INVOLUNTARY MOVEMENTS OF ANTIPSYCHOTIC INDUCED TARDIVE DYSKINESIA 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr DEEPU C S 
Designation  POST GRADUATE SCHOLAR, DEPARTMENT OF PSYCHIATRY, 
Affiliation  KERALA UNIVERSITY OF HEALTH SCIENCES(KUHS) 
Address  Post Graduate Scholer Department Of Psychiatry Room No 8 National Homoeopathy Research Institute in Mental Health Kurichy,Sachivothamapuram P O, Kottayam, Kerala, 686532

Kottayam
KERALA
686532
India 
Phone  8921903116  
Fax    
Email  deepzzzz118@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SREEJA K R 
Designation  ASSISTANT PROFFESOR 
Affiliation  KERALA UNIVERSITY OF HEALTH SCIENCES(KUHS) 
Address  ASSISTANT PROFFESOR Department Of Psychiatry Room No 6 National Homoeopathy Research Institute in Mental Health Kurichy

Kottayam
KERALA
686532
India 
Phone  9495105766  
Fax    
Email  jaisankarsreeja@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SREEJA K R 
Designation  ASSISTANT PROFFESOR 
Affiliation  KERALA UNIVERSITY OF HEALTH SCIENCES(KUHS) 
Address  ASSISTANT PROFFESOR Department Of Psychiatry Room No 6 National Homoeopathy Research Institute in Mental Health Kurichy

Kottayam
KERALA
686532
India 
Phone  9495105766  
Fax    
Email  jaisankarsreeja@gmail.com  
 
Source of Monetary or Material Support  
National Homoeopathy Research Institute in Mental Health 
 
Primary Sponsor  
Name  Dr DEEPU C S 
Address  National Homoeopathy Research Institute in Mental Health Kurichy,Sachivothamapuram P O, Kottayam, Kerala, 686532 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 2  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DEEPU C S  National Homoeopathy Research Institute in Mental Health  National Homoeopathy Research Institute in Mental Health Kurichy,Sachivothamapuram P O, Kottayam, Kerala, 686532
Kottayam
KERALA 
8921903116

deepzzzz118@gmail.com 
DEEPU C S  OPD, IPD & Peripheral Camps of National Homoeopathy Research Institute in mental Health  National Homoeopathy Research Institute in Mental Health Kurichy,Sachivothamapuram P O, Kottayam, Kerala, 686532
Kottayam
KERALA 
8921903116

deepzzzz118@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethical Committee -National Homoeopathy Research Institute in Mental Health, Kottayam.  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F99||Mental disorder, not otherwise specified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Homoeopathic medicines  After enrollment the case will be repertorised. Appropriate potentized Homoeopathic Medicine will be administered in minimum dose in appropriate potency according to the need of the case. Medicine is administered orally. Repetition will be done when improvement comes to a standstill in a higher potency of the same medicine and if the medicine is not found to be effective the case will be retaken then another appropriate medicine is given. The above homoeopathic intervention will be given for a period of 6 months. 
Comparator Agent  Not applicable  Not applicable 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Participants of any gender in age group 18-80 yrs
Participants having score greater than or equal 2 of AIMS
Psychiatric patients who are under antipsychotic treatment for at least 3 months if below 60  
 
ExclusionCriteria 
Details  Those with stereotyped movement disorders
Pregnant and lactating women
Those with antipsychotic withdrawal emergent dyskinesia
Those who are in alcohol withdrawal state 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Assessment of reduction in the severity of TD after Homoeopathic medicines by using AIMS  AIM Scale at baseline and at the end of study (after 6 months ) 
 
Secondary Outcome  
Outcome  TimePoints 
To find out the general improvement of the patient  QOL Scale at baseline & at the end of study (after 6 months ) 
 
Target Sample Size   Total Sample Size="38"
Sample Size from India="38" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   06/07/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Clinical Study Report

  3. Who will be able to view these files?
    Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.

  4. For what types of analyses will this data be available?
    Response - For individual participant data meta-analysis.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [deepzzzz118@gmail.com].

  6. For how long will this data be available start date provided 26-06-2025 and end date provided 11-11-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary    This prospective open label single arm study evaluates the effectiveness of Homoeopathic Medicines in reducing the abnormal involuntary movements of anti psychotic induced Tardive Dyskinesia using Abnormal Involuntary Movement Scale(AIMS) Secondary objective include assessing improvements in quality of life of patient through WHO-QOL BREF scale .Patients will be recruited from the Out patient Department(OPD),In patient Department(IPD),and Peripheral Centres of the National Homoeopathic Research Institute in Mental Health (NHRIMH), Kottayam, following screening based on Verbal Screening Questioner Enrolment requires psychiatric confirmation ,and informed consent/Assent will be obtained from legally authorised representative in English and Malayalam .Baseline assessment include AIMS for severity, with evaluations conducted monthly and tri-monthly, respectively ,while quality of lifewillbemonitoredusingtheWHO-QOLBREFscale.Adetailedcasehistoryandoneon the case recording format and indicated Homoeopathic remedies will be prescribed based on repertorization via RADAR OPUS software and in comparison with Homoeopathic Materia Medica. Patients missing follow-ups for three consecutive months will be considered dropouts and will receive standard  OPD care but will be excluded from further study evaluation. The study aims to provide effectiveness of Homoeopathy’s role as an adjuvant therapy in Tardive Dyskinesia, assessing its ability to improve symptoms and enhance the quality of life 
Close